Search

everythinglearnresearchcommunity

for

Search:↓

Dermatoscopy can help diagnose CCCA without visible hair loss, offering a less invasive option than biopsy.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

CCCA may be caused by both hair traction and an immune response.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Low-dose metformin may help hair regrowth and reduce inflammation in CCCA.

Topical metformin 10% cream may help treat central centrifugal cicatricial alopecia.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

Accurate diagnosis is crucial for effective treatment of hair loss.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Enlarged sweat gland ducts may indicate scarring hair loss.

Hair transplant combining scalp and beard hair with PRP was successful for scarring alopecia.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

The document concludes that "hot comb alopecia" is now called "central cicatricial centrifugal alopecia" and its causes are complex.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Some people experienced hair loss after mesotherapy treatments for hair loss.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

The HoVert technique is a simple, cost-effective new method that improves alopecia diagnosis by allowing detailed analysis from a single biopsy.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.